Overall, our results suggest that astrogliosis and microglial gene activation in APP/PS1 mice are significantly reduced by curative PEL24-199 treatment, and both processes might contribute to the rescue of the amyloid pathology and memory impairment in our PEL24-199-treated APP/PS1 mice. This evidence concerns the gene APP and amyloidosis.